Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV Study to Investigate Differential Immune Effects of Natalizumab

NCT00859482 is registered in ClinicalTrials.gov with Cantonal Hospital of St. Gallen as lead sponsor.

NCT NCT00859482
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00859482 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV Study to Investigate Differential Immune Effects of Natalizumab
Lead sponsor
Cantonal Hospital of St. Gallen
Phase
Observational
Overall status
Completed
Start date
July 31, 2006
Completion date
July 31, 2007
Enrollment
27 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis, relapsing remitting